PRICING
Affordability of a drug for patients is a major concern when prices are determined, as a pharmaceutical company has to consider competition in the market.
LEARN MORE >>ENFORCEMENT OF LAWS AND REGULATIONS
Intellectual Property Rights (IPR) violations are a serious cost to any research based pharmaceutical industry; it can also lead to issues such as counterfeiting and production of sub-standard drugs.
LEARN MORE >>PUBLIC PROCUREMENT OF DRUGS
Pharmaceutical companies are applying for tenders on breakeven prices i.e. on no profit no loss basis, for certain drugs as to assist the government to achieve their healthcare objectives.
LEARN MORE >>PUBLIC PRIVATE PARTNERSHIPS
Public and private sector collaboration improves service, effectiveness and efficiency and helps reduce cost.
LEARN MORE >>NEW INVESTMENT
Investments in technology upgrades should be made duty free, as it would bring innovation and efficiency in the pharmaceutical sector.
LEARN MORE >>CONTRACT MANUFACTURING
Instead of defining a term limit for contract manufacturing, licenses should be awarded to only those pharmaceutical companies that adhere strictly to the cGMPs (current Good Manufacturing Practices).
LEARN MORE >>
NEWS
Price of No Quality
6 March 2018The real price paid by a patient is when an ailment goes untreated due to application of substandard medicines. Recent studies even suggest that substandard medicines might be the cause of the spread of drug resistant diseases in Pakistan.
Asif Jooma Inspires at the Fifth Session of 'Leaders at LUMS'
24 February 2018Drug resistant strain of Typhoid
22 February 2018
DOWNLOADS
Newsletter - May 2018
7 June 2018
Newsletter - December 2017
1 January 2018
Newsletter - November 2017
4 December 2017
Newsletter - October 2017
1 November 2017
Newsletter - December 2016
30 December 2016
